DK1296691T3 - Anvendelse af cellulosesulfat og andre sulfaterede polysaccharider til forebyggelse og behandling af papillomvirusinfektioner - Google Patents

Anvendelse af cellulosesulfat og andre sulfaterede polysaccharider til forebyggelse og behandling af papillomvirusinfektioner

Info

Publication number
DK1296691T3
DK1296691T3 DK01947089T DK01947089T DK1296691T3 DK 1296691 T3 DK1296691 T3 DK 1296691T3 DK 01947089 T DK01947089 T DK 01947089T DK 01947089 T DK01947089 T DK 01947089T DK 1296691 T3 DK1296691 T3 DK 1296691T3
Authority
DK
Denmark
Prior art keywords
inhibiting
preventing
papilloma virus
cellulose sulfate
prevention
Prior art date
Application number
DK01947089T
Other languages
English (en)
Inventor
Thomas C Usher
Robert A Anderson
Lourens J D Zaneveld
Original Assignee
Univ Rush Medical Center
Polydex Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rush Medical Center, Polydex Pharma filed Critical Univ Rush Medical Center
Application granted granted Critical
Publication of DK1296691T3 publication Critical patent/DK1296691T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DK01947089T 2000-06-30 2001-06-29 Anvendelse af cellulosesulfat og andre sulfaterede polysaccharider til forebyggelse og behandling af papillomvirusinfektioner DK1296691T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21532500P 2000-06-30 2000-06-30

Publications (1)

Publication Number Publication Date
DK1296691T3 true DK1296691T3 (da) 2006-03-20

Family

ID=22802531

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01947089T DK1296691T3 (da) 2000-06-30 2001-06-29 Anvendelse af cellulosesulfat og andre sulfaterede polysaccharider til forebyggelse og behandling af papillomvirusinfektioner

Country Status (9)

Country Link
US (3) US7078392B2 (da)
EP (1) EP1296691B1 (da)
AT (1) ATE308329T1 (da)
AU (1) AU2001268884A1 (da)
CA (1) CA2414320C (da)
DE (1) DE60114620T2 (da)
DK (1) DK1296691T3 (da)
ES (1) ES2253395T3 (da)
WO (1) WO2002002189A2 (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003023045A1 (fr) * 2001-09-06 2003-03-20 Techno Network Shikoku Co.,Ltd. Polysaccharides sulfates, procede de production et substances contenant ceux-ci comme ingredient actif
US20050009782A1 (en) * 2003-07-09 2005-01-13 Comper Wayne D. Antiviral charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and methods of use thereof
JP2005108098A (ja) * 2003-10-01 2005-04-21 Hitachi Ltd データｉ／ｏ装置及びデータｉ／ｏ装置の制御方法
US8097210B2 (en) * 2004-12-17 2012-01-17 Bayer Healthcare Llc Disposable test sensor cartridge
EP1842545A1 (en) * 2006-04-04 2007-10-10 Marinomed Biotechnologie GmbH Anti-inflammatory polymer
ATE424834T1 (de) * 2006-04-04 2009-03-15 Marinomed Biotechnologie Gmbh Zellulosesulfat zur behandlung von rhinovirus- infektionen
WO2007112966A1 (en) * 2006-04-04 2007-10-11 Marinomed Biotechnologie Gmbh Cellulose sulfate for the treatment of rhinovirus infection
US20100055060A1 (en) * 2006-11-27 2010-03-04 Naoyuki Yoshida Cosmetic composition
US20080131454A1 (en) * 2006-12-05 2008-06-05 Marinomed Biotechnologie Gmbh Methods and Compositions for the Treatment of Rhinovirus Infections with Carrageenan
US20080268022A1 (en) * 2007-02-23 2008-10-30 Mccabe R Tyler Mehtods for treating and preventing ailments caused by human papillomavirus
JP2008266265A (ja) * 2007-04-24 2008-11-06 Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho 抗ウイルス剤
CN101784272B (zh) 2007-08-24 2014-03-12 玛丽诺姆德生物技术公司 包含硫酸多糖的抗病毒组合物
US20090118352A1 (en) * 2007-11-07 2009-05-07 Esawtech, Ltd. Broad spectrum microbicidal and spermicidal compositions and methods
US8501214B2 (en) * 2007-11-26 2013-08-06 Modetex Biomedical Materials & Technology Industrial Corp. Hydrophilic foam and pharmaceutical dosage form employing the same
JP5702526B2 (ja) * 2009-04-30 2015-04-15 Ｅｓファイバービジョンズ株式会社 抗ウイルス性を有する硫酸化セルロースを担持させた繊維集合体
TWI401096B (zh) * 2009-12-31 2013-07-11 用以治療、管理或預防陰道感染或子宮頸癌的醫藥劑型及其所包含之膠體組成物與親水性泡綿
MD4110C1 (ro) * 2010-10-21 2011-12-31 Валериу РУДИК Preparat antiherpetiс
FR2989001B1 (fr) 2012-04-06 2017-07-21 Centre Nat Rech Scient Microparticules et nanoparticules constituees de polysaccharides hydrophobises et d'une alpha-cyclodextrine
FR2998176B1 (fr) 2012-11-16 2015-01-16 Univ Blaise Pascal Clermont Ii Composition de polysaccharide sulfate
WO2014147287A1 (en) 2013-03-21 2014-09-25 Jukka Seppälä Nanocrystalline cellulose (ncc) as an antiviral compound
EP3204016B1 (en) * 2014-10-06 2021-08-25 Algamed Therapeutics (A.M.T) Ltd. Compositions comprising sulfated polysaccharides and uses thereof
CN105748506B (zh) * 2016-03-03 2018-08-17 青岛海洋生物医药研究院股份有限公司 褐藻酸硫酸酯在制备预防和治疗由人乳头瘤状病毒引起的疾病的药物和保健品中的应用
EP3939597A1 (en) * 2020-07-16 2022-01-19 Marinomed Biotech AG Antiviral pharmaceutical composition comprising a carrageenan component

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL70511A (en) 1982-12-28 1990-01-18 Anic Spa Process for the concurrent depolymerization and sulfation of polysaccharides at hydroxyl groups
FR2542616B1 (fr) * 1983-03-17 1987-07-31 Unilever Nv Composition pour le traitement des muqueuses a base d'un antibiotique et d'un hydrocolloide formateur de gel
EP0240098A3 (en) * 1986-04-04 1989-05-10 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Oligo and polysaccharides for the treatment of diseases caused by retroviruses
EP0298706B1 (en) 1987-07-07 1994-09-07 Ajinomoto Co., Inc. Use of glycans in the manufacturing of anti-viral medicaments.
EP0402078A3 (en) * 1989-06-06 1991-07-31 Patrick Daniel Kelly Sexual lubricants containing zinc as an anti-viral agent
US5208031A (en) * 1989-06-06 1993-05-04 Kelly Patrick D Sexual lubricants containing zinc as an anti-viral agent
AU1052492A (en) * 1991-01-31 1992-08-06 Farmitalia Carlo Erba S.R.L. Synergistic composition comprising a fibroblast growth factor and a sulfated polylsaccharide, for use as antiviral agent
CA2146988A1 (en) * 1992-10-13 1994-04-28 Gideon Strassmann Treatment of cachexia and inhibition of il-6 activity
ES2142407T3 (es) * 1993-09-20 2000-04-16 Ajinomoto Kk Antimalaria.
US6063773A (en) * 1995-09-29 2000-05-16 Polydex Pharmaceuticals Ltd. Cellulose sulfate for use as antimicrobial and contraceptive agent
US6239182B1 (en) * 1995-10-13 2001-05-29 Rush-Presbyterian-St. Lukes Medical Center Method for preventing sexually transmitted diseases
US5741525A (en) * 1995-10-24 1998-04-21 Marshall University Research Corporation Vaginal pharmaceutical hydrogen peroxide composition
US5955096A (en) * 1996-06-25 1999-09-21 Brown University Research Foundation Methods and compositions for enhancing the bioadhesive properties of polymers using organic excipients
US5853767A (en) * 1997-01-02 1998-12-29 Melman; Steven A. Compositions for treating fungal, parasitic and/or bacterial infections, especially infections of organs such as the skin and vagina
JPH1180003A (ja) * 1997-09-16 1999-03-23 Yakult Honsha Co Ltd 感染症予防・治療剤

Also Published As

Publication number Publication date
CA2414320A1 (en) 2002-01-10
AU2001268884A1 (en) 2002-01-14
EP1296691A2 (en) 2003-04-02
US7235536B2 (en) 2007-06-26
US7226914B2 (en) 2007-06-05
ATE308329T1 (de) 2005-11-15
EP1296691B1 (en) 2005-11-02
US20050203055A1 (en) 2005-09-15
US7078392B2 (en) 2006-07-18
CA2414320C (en) 2008-04-01
DE60114620D1 (de) 2005-12-08
ES2253395T3 (es) 2006-06-01
US20030181415A1 (en) 2003-09-25
US20050143342A1 (en) 2005-06-30
WO2002002189A2 (en) 2002-01-10
DE60114620T2 (de) 2006-07-27
WO2002002189A3 (en) 2002-09-19

Similar Documents

Publication Publication Date Title
DK1296691T3 (da) Anvendelse af cellulosesulfat og andre sulfaterede polysaccharider til forebyggelse og behandling af papillomvirusinfektioner
DK1458360T3 (da) Pulmonær afgivelse af aminoglycosider
NO20045247L (no) Nukleosidderivater for behandling av hepatitt C-virusinfeksjon
BR0116519B1 (pt) cartucho de hemodiafiltraÇço/hemofiltraÇço de diluiÇço intermediÁria.
NO20075655L (no) Terapeutisk RNAI for respiratorisk virusinfeksjon
DE60124684D1 (de) Sulfonamido-substituierte verbrückte bicycloalkylderivative
ATE516022T1 (de) Antimikrobielle zusammensetzungen und anwendungsverfahren dafür
ATE512976T1 (de) Hemmer des hepatitis-c-virus
WO2005046618A3 (en) Methods of treating eczema
ATE344031T1 (de) Thrombopoietin-mimetika
EA200300948A1 (ru) Водная композиция амфотерицина b
FR2774900B1 (fr) Shampoings antipelliculaires transparents
BR0114449A (pt) Composições de limpeza contendo quitosana
BR0212312A (pt) Clone infeccioso do vìrus da diarréia viral bovina
DE69909747D1 (de) Pharmazeutische zusammensetzung, enthaltend peg-asparaginase, für die behandlung von hiv infektionen
SE0004101D0 (sv) New use
NO20032406L (no) Anvendelse av 1-fenyl-3-dimetylaminopropanforbindelser for behandling av urininkontinens
BR0209145A (pt) Vacina contra varìola
WO2002000613A3 (en) Inhibitors of hepatitis b virus infection
ATE435028T1 (de) Impfstoff gegen neisseria infektion
ATE476987T1 (de) Zusammensetzungen und methoden zur behandlung von candidosen
ATE299027T1 (de) Verwendung von übersulfatierten polysacchariden als hiv-hemmer
ATE302008T1 (de) Behandlung von entzündlichen erkrankungen
DE60237821D1 (de) Antibakterielle behandlung von osteoarthritis
EP1552823A3 (en) Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections